People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...
Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...
The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...
Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...
This may further reduce CCK sensitivity, creating a negative feedback loop. PYY is a gut hormone that decreases appetite. PYY levels may be lower in people with obesity, and this may lead to a ...
Obesity is a common health problem affecting a considerable (and growing) proportion of adult populations worldwide.1 Although overweight and obesity are usually diagnosed by anthropometry, such as ...
Manufactured by Eli Lilly and Company, both Mounjaro and Zepbound contain the active ingredient tirzepatide. Tirzepatide is similar to semaglutide, which is used in medications like Ozempic, Rybelsus, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results